Uy GL, et al. Blood (2012) cited as Ref 630 in DOI: 10.1038/s41392-020-0110-5 (Q9893)
Revision as of 22:05, 20 May 2020 by Admin (talk | contribs) (Created claim: Property:P93: A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia, #quickstatements; #temporary_batch_1590010982689)
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Uy GL, et al. Blood (2012) cited as Ref 630 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Uy GL
0 references
2012
0 references
Blood
0 references
119
0 references
A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia (English)
0 references
